Inventor
KAISER CARL
US51 patents
⚠️ This page may combine multiple inventors who share the name “KAISER CARL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SMITHKLINE CORP
24 patentsUS4265890AMay 5, 1981
6-Phenyl thio- and 6-cyclohexyl thio-2,3,4,5-tetrahydro-1H-3-benzazepines
SMITHKLINE CORP30 citations92
US4011319AMar 8, 1977
Pharmaceutical compositions and methods involving benzazepine derivatives
SMITHKLINE CORP23 citations82
US3988339AOct 26, 1976
Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase
SMITHKLINE CORP23 citations82
US3952101AApr 20, 1976
α-Amino methyl-5-hydroxy-2-pyridinemethanols
SMITHKLINE CORP30 citations78
US4004028AJan 18, 1977
Phenoxypropanolamines
SMITHKLINE CORP17 citations74
US3976694AAug 24, 1976
α-Aminoalkyl-4-hydroxy-3-alkylsulfonylmethylphenyl ketones
SMITHKLINE CORP8 citations73
US4048229ASep 13, 1977
α-AMINOMETHYL-4-HYDROXY-3-METHYLSULFONYL BENZYL ALCOHOLS
SMITHKLINE CORP7 citations72
US3933913AJan 20, 1976
N,N'-bis[3-substituted-4-hydroxypheyl)-2-hydroxyethyl)]-polymethylenediamines
SMITHKLINE CORP15 citations72
US3985887AOct 12, 1976
3-Substituted-4-hydroxyphenyl-2-piperidylcarbinols as β-adrenergic stimulants
SMITHKLINE CORP15 citations70
US3976695AAug 24, 1976
Halogen substituted α-(aminoalkyl)-3,4-dihydroxybenzyl alcohols
SMITHKLINE CORP12 citations70
US4073912AFeb 14, 1978
Piperidylidene derivatives of benzo-fused xanthenes, thioxanthenes and dibenzoxepins and antipsychotic use thereof
SMITHKLINE CORP10 citations68
US4052506AOct 4, 1977
Pharmaceutical compositions and method of producing anti-parkinsonism activity
SMITHKLINE CORP8 citations68
US4327023AApr 27, 1982
Intermediates for preparing 7,8-amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
SMITHKLINE CORP3 citations63
US4284556AAug 18, 1981
7,8-Amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
SMITHKLINE CORP2 citations63
US3966770AJun 29, 1976
4-Hydroxy-α-[(3,4-methylenedioxyphenyl)isopropylaminoethyl]-3-(methylsulfonylmethyl)benzyl alcohol
SMITHKLINE CORP2 citations62
US3939164AFeb 17, 1976
7 AND 8-Halo substituted 1,2,3,4-tetrahydroisoquinoline compounds
SMITHKLINE CORP5 citations62
US4024281AMay 17, 1977
N,N-bis[2-(3-substituted-4-hydroxyphenyl)-ethyl or -2-hydroxyethyl]-polymethylenediamines
SMITHKLINE CORP3 citations61
US3943173AMar 9, 1976
3-Alkylamino- alpha-aminomethyl-4-hydroxybenzyl alcohols
SMITHKLINE CORP5 citations61
US3943254AMar 9, 1976
Beta-adrenergic antagonists
SMITHKLINE CORP5 citations61
US4012528AMar 15, 1977
α-AMINOALKYL-3-(1,2-DIHYDROXYETHYL)-4-HYDROXY-BENZYL ALCOHOLS HAVING β-ADRENERGIC STIMULANT ACTIVITY
SMITHKLINE CORP3 citations54
US4062961ADec 13, 1977
Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase
SMITHKLINE CORP1 citations52
US3961076AJun 1, 1976
α-Aminoalkyl-4-hydroxy-3-alkylsulfonylmethylbenzyl alcohols having β-adrenergic stimulant activity
SMITHKLINE CORP0 citations52
US4013777AMar 22, 1977
Bis-phenoxypropanolamines
SMITHKLINE CORP0 citations51
US3996383ADec 7, 1976
3-Alkylamino-α-aminomethyl-4-hydroxybenzyl alcohols with β-adrenergic stimulant activity
SMITHKLINE CORP1 citations51
SMITHKLINE BECKMAN CORP
19 patentsUS4760089AJul 26, 1988
Irreversible dopamine-β-hydroxylase inhibitors
SMITHKLINE BECKMAN CORP27 citations91
US4532331AJul 30, 1985
1-Benzyl-2-aminomethyl imidazole derivatives
SMITHKLINE BECKMAN CORP23 citations82
US4719223AJan 12, 1988
Imidazolethiol dopamine-beta-hydroxylase inhibitors
SMITHKLINE BECKMAN CORP6 citations74
US4707485ANov 17, 1987
Substituted te[1]trahydroisoquinoline derivatives having β-adrenergic receptor activity
SMITHKLINE BECKMAN CORP11 citations74
US4634711AJan 6, 1987
Pyridylalkyl imidazole-2-thiols
SMITHKLINE BECKMAN CORP10 citations74
US4529604AJul 16, 1985
N,N-Di-(n-Propyl)dopamine derivatives
SMITHKLINE BECKMAN CORP6 citations73
US4769368ASep 6, 1988
2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines
SMITHKLINE BECKMAN CORP11 citations72
US4507320AMar 26, 1985
Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine
SMITHKLINE BECKMAN CORP8 citations71
US4728741AMar 1, 1988
1-substituted-2-mercapto benzimidazole compounds and intermediates
SMITHKLINE BECKMAN CORP4 citations63
US4707488ANov 17, 1987
Dopamine-β-hydroxylase inhibitors and use thereof
SMITHKLINE BECKMAN CORP2 citations63
US4772723ASep 20, 1988
Dopamine β-hydroxylase inhibitors
SMITHKLINE BECKMAN CORP3 citations62
US4743613AMay 10, 1988
Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
SMITHKLINE BECKMAN CORP3 citations62
US4873357AOct 10, 1989
Trifluoro acetyl-cyano-aniline intermediates for dopamine-βhydroxylase inhibitors
SMITHKLINE BECKMAN CORP0 citations52
US4857540AAug 15, 1989
Dopamine-β-hydroxylase inhibitors
SMITHKLINE BECKMAN CORP0 citations52
US4810811AMar 7, 1989
Dopamine-beta-hydroxylase inhibitors
SMITHKLINE BECKMAN CORP0 citations52
US4767862AAug 30, 1988
Substituted tetrahydro isoquinoline intermediates
SMITHKLINE BECKMAN CORP0 citations52
US4761480AAug 2, 1988
P-toluene-sulfonyl-oxy substituted pyridines
SMITHKLINE BECKMAN CORP0 citations52
US4382029AMay 3, 1983
Process useful for preparing 7,8-acetamido, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
SMITHKLINE BECKMAN CORP1 citations52
US4863944ASep 5, 1989
Dopamine-β-hydroxylase inhibitors
SMITHKLINE BECKMAN CORP1 citations51
SCIOS NOVA INC
1 patentMARION MERRELL DOW INC
1 patentWOODS HOLE OCEANOGRAPHIC INST
1 patentSMITHKLINE BEECHAM CORP
1 patentMARION LABORATORIES INC
1 patentSMITHKLEIN BECKMAN CORP
1 patentSAILDRONE INC
1 patentShowing the top 50 of 51 patents by PatentIndex Score.